GNH USA

Europe — EMA

Evfraxy

Evfraxy (Denosumab) is a subcutaneous medication used to treat bone-related conditions. Learn about its uses, effects, and precautions for managing bone health.

Denosumab

Request sourcing

1
Pack/s

What is Denosumab?

Evfraxy (Denosumab) is a subcutaneous medication used to treat bone-related conditions. Learn about its uses, effects, and precautions for managing bone health.

What is Denosumab used for?

Evfraxy (Denosumab) is primarily used for the treatment of conditions related to bone health. It is often prescribed for osteoporosis and other bone disorders to help improve bone density and reduce the risk of fractures. This medication works by targeting specific cells involved in bone breakdown, thereby promoting stronger bones. What is Evfraxy used for? It is commonly used to manage bone loss and improve bone strength in individuals with conditions that affect bone health.

What are the side effects of Denosumab?

Common effects of Evfraxy (Denosumab) may include mild to moderate reactions at the injection site, such as redness, swelling, or itching. Some individuals may experience joint pain, back pain, or upper respiratory infections. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

What precautions apply to Denosumab?

When using Evfraxy (Denosumab), it is important to follow the prescribed dosage and administration instructions. This medication should be stored properly and used as directed. Individuals with a history of allergic reactions to Denosumab or any of its components should avoid using this medication. Always consult a healthcare provider before starting any new medication.

What does Denosumab interact with?

Evfraxy (Denosumab) may interact with other medications, including those that affect the immune system or bone metabolism. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication, so it is advisable to discuss these with a healthcare professional.

Frequently asked questions

What is Evfraxy used for?+
Evfraxy (Denosumab) is used to treat bone-related conditions, such as osteoporosis, to improve bone density and reduce the risk of fractures.
How is Evfraxy administered?+
Evfraxy is administered via subcutaneous injection, typically every six months, as prescribed by a healthcare provider.
What are the common side effects of Evfraxy?+
Common side effects may include injection site reactions, joint pain, back pain, and upper respiratory infections.
Can Evfraxy be used with other medications?+
Evfraxy may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.
Who should avoid using Evfraxy?+
Individuals with a history of allergic reactions to Denosumab or any of its components should avoid using Evfraxy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Denosumab
Route
Subcutaneous Use
Manufacturer
Biosimilar Collaborations Ireland Limited
Origin
EU

Related products